Free provider profile
ROBERT SCHUSTER, MD
Need more providers like ROBERT SCHUSTER?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What ROBERT SCHUSTER prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Eliquis
- Farxiga
- Mounjaro
- Ozempic
- Invega Sustenna
See all family medicine physicians in AL who bill Medicare →
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
256-825-7871
Fax
256-825-5742
Practice address
301 MARIARDEN RD STE D, DADEVILLE, AL, 36853
- Registry updated
- 2011-04-04
- NPI issued
- 2006-07-07
- RepVector retrieved
- 11/21/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
301 MARIARDEN RD STE D, DADEVILLE, AL, 36853
256-825-7871
Single practice location
Enumerated 2006-07-07
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 15 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
33,512
Medicare patients
954
Part D drug cost
$3,329,239
Brand-name share
9.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Invega Sustenna (Paliperidone Palmitate) | 81 | $260,618 |
| Austedo (Deutetrabenazine) | 25 | $219,770 |
| Abilify Maintena (Aripiprazole) | 77 | $195,557 |
| Eliquis (Apixaban) | 472 | $175,257 |
| Ingrezza (Valbenazine Tosylate) | 19 | $164,771 |
| Farxiga (Dapagliflozin Propanediol) | 207 | $153,836 |
| Mounjaro (Tirzepatide) | 144 | $151,764 |
| Ozempic (Semaglutide) | 103 | $116,497 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across AL — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
